Cargando…
Paracrine IL-6 Signaling Confers Proliferation between Heterogeneous Inflammatory Breast Cancer Sub-Clones
SIMPLE SUMMARY: This study provides novel mechanistic insights into the capacity of the inflammatory cytokine IL-6 and its associated STAT3-dependent signaling pathway to stimulate proliferation in trans between individual sub-clones in a model of heterogeneity in inflammatory breast cancer. The cli...
Autores principales: | Morrow, Riley J., Allam, Amr H., Yeo, Belinda, Deb, Siddhartha, Murone, Carmel, Lim, Elgene, Johnstone, Cameron N., Ernst, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105876/ https://www.ncbi.nlm.nih.gov/pubmed/35565421 http://dx.doi.org/10.3390/cancers14092292 |
Ejemplares similares
-
Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer
por: Morrow, Riley J., et al.
Publicado: (2017) -
Paracrine IL-33 Stimulation Enhances Lipopolysaccharide-Mediated Macrophage Activation
por: Ohno, Tatsukuni, et al.
Publicado: (2011) -
Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016) -
Multicentre evaluation of the IL Densiscan
por: Bonini, P. A., et al.
Publicado: (1986) -
CloneSifter: enrichment of rare clones from heterogeneous cell populations
por: Feldman, David, et al.
Publicado: (2020)